Boston Therapeutics Stock Price (OTCBB:BTHE)

Add to My Stocks
$0.04 $0 (0%) BTHE stock closing price Sep 19, 2018 (Closing)
Prev Close* : $0.04
Market Cap:
Day Low: $0.04
52 Week Low: $0.03
Open: $0.04
Volume: $230
Day High: $0.04
52 Week High: $0.12

Latest Stock Market News

Latest Articles

Boston Therapeutics News - From Partners

Boston Therapeutics Business Update   by Marketwired on Feb 07, 2017
Boston Therapeutics Announces Innovation Grant   by Marketwired on Oct 13, 2016

BTHE Stockcharts

View BTHE PE ratio, PS ratio stocks charts and compare with peers.
BTHE Chart
Note: Compare Boston Therapeutics stock price history with the index and industry peers.

Boston Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Boston Therapeutics Returns

(return on equity)

Boston Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

BTHE Industry Peers

Company Price Change (%)
Biostar Pharma (BSPM)1.950.07 (3.72%)
Praxsyn (PXYN)0.010 (0%)
Lexicon Pharma (LXRX)10.750.23 (2.09%)
Integrated Biopharma (INBP)0.180 (0%)
Lexicon Pharma (LXRX)10.750.23 (2.09%)
Viking Therapeutics (VKTX)19.650.19 (0.98%)
Viking Therapeutics (VKTX)19.650.19 (0.98%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Boston Therapeutics Inc Stock News - Partner Headlines

Boston Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-1.58M-3.73M-2.48M-4.69M-4.6M
Total Operating Expense1.06M1.18M1.6M4.69M4.08M
View Boston Therapeutics income statement
balance sheet20172016201520142013
Total Assets-1.4M-1.16M4.53M
Total Liabilities4.78M4.52M1.4M1.08M1.18M
Shareholders Equity-3.88M-3.11M-0.53M-3.34M
View Boston Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-----
Net Cash from (used by) Operating Activities-1.27M-1.24M-1.29M-3.47M-2.33M
Increase (Decrease) in Prop Plant And Equipment----0.01M-0.01M
View Boston Therapeutics cash flow statement

Boston Therapeutics Stock Message Board

As of last trading day, Boston Therapeutics stock price was $0.04. The total market value as denoted by $4.42M for Boston Therapeutics, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Boston Therapeutics valuation, even though in the short-term, sentiment and current breaking news might affect Boston Therapeutics stock price.

The terms stocks and shares mean the same thing. For Ex: Boston Therapeutics stock price and Boston Therapeutics share price mean the same thing. The volume number in Boston Therapeutics stock quote data shows the number of shares traded. For Ex: 230 Boston Therapeutics shares were traded as of last trading day, as seen from Boston Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Boston Therapeutics dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Boston Therapeutics stock price history.